This website uses cookies
Read our Privacy policy and Terms of use for more information.
Upgrade to EverLife Premium for the complete Tracker, Scout list and Watchlist, 25-gate company scores, publicly sourced valuation context, plain-English mechanism explanations and continuing milestone updates.
The complete company Tracker, Scout list and Watchlist
The date each company entered the framework, framework scores and publicly supportable valuation information
Plain-English explanations of each company's technology and mechanism
Human evidence separated from animal, laboratory and biomarker findings
The next milestone that could strengthen or weaken each research case
Free readers receive the weekly company briefing. Premium members unlock the complete company research records, downloadable workbooks, framework scores, valuation context, evidence reviews and continuing Tracker updates.
EverLife is for business owners, successful professionals, founders and investors who want more healthy years, want to understand promising longevity biotechs before the field becomes mainstream, and do not want to chase every exciting headline. It is not for anyone seeking guaranteed returns, personalized investment advice, medical advice or a list of securities to buy.
Is this investment advice?
No, it is general and impersonal educational research.
Will you tell me what to buy?
No. The research shows what is being tracked, what is missing and what could change the assessment.
How often does the tracker change?
When material evidence changes a company thesis, the current tracker and thesis-change record are updated.
Can private companies appear?
Yes, when access, valuation and evidence limitations are clearly identified.
Membership does not remove biotechnology risk. Trials fail, financing can dilute shareholders, private interests may be inaccessible or illiquid, and securities can result in total loss. Read the full disclosure and terms of research.